10th Annual Cardiovascular Disease Update

Release Date: December 5, 2016
Expiration Date: December 4, 2019


Program Agenda

Introduction and Welcome
Marco Costa, MD, PhD

Is ARB/neprilysin inhibitor (LCZ696) preferred to ACE inhibitor for all patients with heart failure?
Chantal ElAmm, MD

Adult congenital heart disease management and transcatheter therapies program
Martin Bocks, MD

Novel stroke prevention strategies for patients with atrial fibrillation
Hiram Bezerra, MD, PhD

New Aortic Center: Aortic valve to iliac bifurcation
Vikram Kashyap, MD, and Yakov Elgudin, MD, PhD

Cardiovascular medicine and surgery procedural primer for the nonproceduralist
Mauricio Arruda, MD, Guilherme Attizzani, MD, and Basar Sareyyupoglu, MD 

 

Clinical Case Management

Moderator: Atul Hulyalkar, MD

Panel:
Teresa Carman, MD
Sahil Parikh, MD
Soon Park, MD
Monique Robinson, MD
Dina Sparano, MD
A. Roger Tsai, MD
William Wolf, MD
Virginia Wong, MD

Acknowledgments
Educational grants from Abbott Laboratories, Boston Scientific and Medtronic in support of this activity are gratefully acknowledged. 

Faculty

Marco Costa, MD, PhD
Activity Director
Chief Innovation Officer, University Hospitals
President, UH Harrington Heart & Vascular Institute
Angela & James Hambrick Master Clinician of Cardiovascular Innovation
Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Costa has received honoraria from Edwards Lifesciences and Medtronic, and consulting payments from CardioKenetix, and the CME Program has determined there is no conflict of interest. 

Mauricio Arruda, MD
Director, Electrophysiology Center
Director, Atrial Fibrillation Center
UH Harrington Heart & Vascular Institute
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Arruda reports no financial relationship with a commercial interest relevant to this activity.

Guilherme Attizzani, MD
Interventional Cardiovascular Center
UH Harrington Heart & Vascular Institute
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Attizzani has received honoraria from Medtronic and Edwards, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Hiram Bezerra, MD, PhD
Director, Cardiac Catheterization Laboratories
UH Cleveland Medical Center
Director, Cardiovascular Imaging Core Laboratories
Co-Director, Cardiovascular CT/MRI Center
UH Harrington Heart & Vascular Institute
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Bezerra has received consulting fees from Abiomed and Medtronic, and the CME Program has determined there is no conflict of interest. 

Martin Bocks, MD
Director, Pediatric Interventional Cardiology
The Congenital Heart Collaborative
UH Rainbow Babies and Children’s Hospital
Adult Congenital Heart Disease Center
UH Harrington Heart & Vascular Institute
Associate Professor of Pediatrics
Case Western Reserve University School of Medicine
Dr. Bocks has received consulting fees from Edwards Lifesciences, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Teresa Carman, MD
Director, Vascular Medicine
Medical Director, Center for Wound Care
UH Cleveland Medical Center
Medical Director, Anticoagulation Monitoring Service
UH Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Carman reports no financial relationship with a commercial interest relevant to this activity.

Chantel ElAmm, MD
Advanced Heart Failure & Transplant Center
UH Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. ElAmm reports no financial relationship with a commercial interest relevant to this activity.

Yakov Elgudin, MD, PhD
Co-Director, Aortic Center
Co-Director, Coronary Clinic
UH Harrington Heart & Vascular Institute
Assistant Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Elgudin reports no financial relationship with a commercial interest relevant to this activity.

Atul Hulyalkar, MD
Medical Director, UH Harrington Heart & Vascular Institute at UH St. John Medical Center
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Hulyalkar reports no financial relationship with a commercial interest relevant to this activity.

Vikram Kashyap, MD
Co-Chair, Clinical Executive Committee
Co-Director, Aortic Center
UH Harrington Heart & Vascular Institute
Chief, Division of Vascular Surgery and Endovascular Therapy
UH Cleveland Medical Center
Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Kashyap has received consulting fees from Silk Road Medical, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.

Sahil Parikh, MD
Director, Research & Innovation Center
UH Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Parikh has received honoraria and research funds from Boston Scientific, Medtronic, St. Jude, Abbott Vascular and Spectranetics, and the CME Program has determined there is no conflict of interest.

Soon Park, MD
Co-Chair, Clinical Executive Committee
UH Harrington Heart & Vascular Institute
Chief, Division of Cardiac Surgery
UH Cleveland Medical Center
Jay C. Akeney, MD, Chair in Cardiothoracic Surgery and Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Park reports no financial relationship with a commercial interest relevant to this activity. 

Monique Robinson, MD, PhD
Advanced Heart Failure & Transplant Center
UH Harrington Heart & Vascular Institute
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Robinson reports no financial relationship with a commercial interest relevant to this activity.

Basar Sareyyupoglu, MD
Heart Surgery Center
UH Harrington Heart & Vascular Institute
Clinical Associate Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Sareyyupoglu reports no financial relationship with a commercial interest relevant to this activity.

Dina Sparano, MD
Director, Electrophysiology Laboratory at UH St. John Medical Center
UH Harrington Heart & Vascular Institute
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Sparano reports no financial interest with a commercial interest relevant to this activity.

A. Roger Tsai, MD
Medical Director, UH Harrington Heart & Vascular Institute at UH Portage Medical Center
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Tsai reports no financial interest with a commercial interest relevant to this activity.

William Wolf, MD
Medical Director, UH Harrington Heart & Vascular Institute at UH Ahuja Medical Center
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Wolf has received consulting fees from AstraZeneca, and the CME Program has determined there is no conflict of interest.

Virginia Wong, MD
Vascular Center
UH Harrington Heart & Vascular Institute
Assistant Professor of Surgery
Case Western Reserve University School of Medicine
Dr. Wong reports no financial relationship with a commercial interest relevant to this activity.

Media: Recorded slides and audio presentation.  Supplementary educational materials may include downloads of videos, print materials, slides or web pages.

Target Audience: This program is intended to update practicing internists, family medicine physicians, primary care physicians, cardiologists, cardiac surgeons, vascular surgeons, physician assistants, nurse practitioners, nurses, residents and fellows on current topics in cardiovascular disease.

Learning Objectives

After participating in this activity, participants will be able to:

  • Discuss the latest advances in heart failure treatment
  • Review new devices and therapies for chronic diseases such as atrial fibrillation, peripheral artrial disease and atherosclerosis
  • Gain an appreciation/understanding of adult patients living with congenital heart disease      
  • Describe new surgical and catheter-based therapies for advanced heart disease patients

Accreditation Statement 

 

 

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee

Marco Costa, MD, PhD
Activity Director
Dr. Costa has received honoraria from Edwards Lifesciences and Medtronic, and consulting payments from CardioKenetix, and the CME Program has determined there is no conflict of interest.

Daniel Simon, MD
Dr. Simon has received honoraria from Medtronic, and the CME Program has determined there is no conflict of interest.

Disclosure Statement
The policy of Case Western Reserve University School of Medicine CME Program (CWRU CME) requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests.  Where disclosures have been made, conflicts of interest, real or apparent, must be resolved.  Disclosure will be made to activity participants prior to the commencement of the activity.  CWRU CME also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of "off-label" or investigational use of pharmaceutical products or medical devices. 

Instructions

To receive a statement of credit for up to 2.0 AMA PRA Category 1 Credits™ you must:

  1. Review the full content of the recorded sessions.
  2. Review any supplementary materials referenced under Resources.
  3. Reflect on the content.
  4. Successfully complete the post-test. A score of 75% is required for passage.
  5. Complete the evaluation.

Your credits will be recorded by the CWRU School of Medicine CME Program and made a part of your cumulative transcript.

Estimated Time of Completion

This activity is expected to take approximately 2 hours to complete.

Fee
There is no fee for this program. 

To contact the CME Provider: E-mail Case Western Reserve University School of Medicine CME at medcme@case.edu

Medical Disclaimer
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The author has checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.

Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive.  Neither the author nor the Case School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.

Learners are encouraged to confirm the information contained herein with other sources.  This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians.  The Case School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising here from.

Resources

McMurray, John JV, et al. "Angiotensin–neprilysin inhibition versus enalapril in heart failure." N Engl J Med 2014; 371(11): 993-1004.

https://www.achaheart.org/provider-support/resources/

http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/CongenitalHeartDefectsToolsResources/Web-Booklet-Adults-With-Congenital-Heart-Defects_UCM_316613_Article.jsp#.WApy302zE-V

Tsai, TT, et al. “Partial thrombosis of the false lumen in patients with acute type B aortic dissection.” N Engl J Med 2007; 35(4): 349-359.

Schermerhorn, Marc L, et al. “Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population.” New England Journal of Medicine 358 (2008):464-474.

Douglas PS, Hoffmann U, Patel MR et al.  “Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease.”  N Engl J Med  2015;372(14):1291=1300.

Douglas PS, Pontone G, Hlatky MA et al.  “Clinical Outcoms of Fractional Flow Reserve by Computed Tomographic Angiography-guided Diagnostic Strategies vs. Usual Care in Patients with Suspected Coronary Artery Disease: the Prospective Longitudinal Trial of FFRct: Outcome and Resource Impacts Study.”  Eur Heart J doi:10.1093/eurheartj/ehv444

Fihn SD, Blankenship JC et al.  “2014 ACC/HA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease.  J Am Coll Cardiol 2014;64(18):1029-1049.

Bittencourt MS, Hulten E, Polonsky TS et al.  European Society of Cardiology- Recommended CAD Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events than the Diamond and Forrester Score Circulation 2016;134:201-211 

McMurray JJV, Packer M, Desai AS et al.  “Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure.”  N Eng J Med. 2014;371(11):993-1004.

Hubers SA, Brown NJ.  “Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.”  Circulation.  2016;133:1115-1124. 

Yancy CW, Jessup M.  “2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.”  J Am Coll Cardiol.  2016;68(13):1476-1488.

Rosenfield K, Matsumura JS, Chaturvedi S et al.  “Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis.”  N Engl J Med.  2016;374(11);1011-1020.

Brott TG, Halperin JL et al.  “2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS?SAIP/SCAI/SIR/SNIS/SVM/SVS Guidelines for Management of Patients with Extracranial Carotid and Vertebral Artery Disease.”  J Am Coll Cardiol.  2011;57(8):e16-e94.

Spence JD.  “Asymptomatic Carotid Stenosis” Circulation.  2013;127:739-742

Presenters

Marco Costa, MD, PhD

Marco Costa, MD, PhD Activity Director
Chief Innovation Officer, University Hospitals
President, UH Harrington Heart & Vascular Institute
Angela & James Hambrick Master Clinician of Cardiovascular Innovation
Professor of Medicine
Case Western Reserve University School of Medicine
View Full Profile

Chantal ElAmm, MD

Chantal ElAmm, MD Advanced Heart Failure & Transplant Center
UH Harrington Heart & Vascular Institute
Assistant Professor of Medicine
View Full Profile

Martin Bocks, MD

Martin Bocks, MD Director, Pediatric Interventional Cardiology
The Congenital Heart Collaborative
UH Rainbow Babies and Children’s Hospital
Adult Congenital Heart Disease Center
UH Harrington Heart & Vascular Institute
Associate Professor of Pediatrics
Case Western Reserve University School of Medicine
View Full Profile

Vikram Kashyap, MD

Vikram Kashyap, MD Co-Chair, Clinical Executive Committee
Co-Director, Aortic Center
UH Harrington Heart & Vascular Institute
Chief, Division of Vascular Surgery and Endovascular Therapy
UH Cleveland Medical Center
Professor of Surgery
Case Western Reserve University School of Medicine
View Full Profile

Yakov Elgudin, MD, PhD

Yakov Elgudin, MD, PhD Co-Director, Aortic Center
Co-Director, Coronary Clinic
UH Harrington Heart & Vascular Institute
Assistant Professor of Surgery
Case Western Reserve University School of Medicine
View Full Profile

Mauricio Arruda, MD

Mauricio Arruda, MD Director, Electrophysiology Center
Director, Atrial Fibrillation Center
UH Harrington Heart & Vascular Institute
Associate Professor of Medicine
Case Western Reserve University School of Medicine
View Full Profile

Guilherme Attizzani, MD

Guilherme Attizzani, MD Interventional Cardiovascular Center
UH Harrington Heart & Vascular Institute
Clinical Assistant Professor of Medicine
Case Western Reserve University School of Medicine
View Full Profile

Basar Sareyyupoglu, MD

Basar Sareyyupoglu, MD Heart Surgery Center
UH Harrington Heart & Vascular Institute
Clinical Associate Professor of Surgery
Case Western Reserve University School of Medicine
View Full Profile

Hiram Bezerra, MD, PhD

Hiram Bezerra, MD, PhD Director, Cardiac Catheterization Laboratories
UH Cleveland Medical Center
Director, Cardiovascular Imaging Core Laboratories
Co-Director, Cardiovascular CT/MRI Center
UH Harrington Heart & Vascular Institute
Associate Professor of Medicine
Case Western Reserve University School of Medicine
View Full Profile